Charles Anello

493 total citations
22 papers, 345 citations indexed

About

Charles Anello is a scholar working on Economics and Econometrics, Statistics and Probability and Toxicology. According to data from OpenAlex, Charles Anello has authored 22 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Economics and Econometrics, 8 papers in Statistics and Probability and 4 papers in Toxicology. Recurrent topics in Charles Anello's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Statistical Methods in Clinical Trials (7 papers) and Advanced Causal Inference Techniques (4 papers). Charles Anello is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Statistical Methods in Clinical Trials (7 papers) and Advanced Causal Inference Techniques (4 papers). Charles Anello collaborates with scholars based in United States and Thailand. Charles Anello's co-authors include Joseph L. Fleiss, Robert T. O’Neill, Elizabeth Franzmann, Dorothy F. Parker, Giovana R. Thomas, Jennifer J. Hu, W. Jarrard Goodwin, Silvina Levis, Satya D. Dubey and Gerald A. Faich and has published in prestigious journals such as American Journal of Epidemiology, Journal of Clinical Epidemiology and Statistics in Medicine.

In The Last Decade

Charles Anello

20 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Charles Anello United States	9	99	67	65	46	45	22	345
Jessica Daw Australia	7	53 0.5×	27 0.4×	23 0.4×	29 0.6×	48 1.1×	20	360
F. Daly United Kingdom	8	16 0.2×	58 0.9×	64 1.0×	17 0.4×	112 2.5×	19	343
Timothy M. Herr United States	6	146 1.5×	133 2.0×	5 0.1×	12 0.3×	28 0.6×	10	506
Dimitris Rucks Varvaki Rados Brazil	14	11 0.1×	153 2.3×	81 1.2×	7 0.2×	72 1.6×	43	673
Fleur T. van de Wetering Netherlands	6	9 0.1×	40 0.6×	51 0.8×	6 0.1×	27 0.6×	11	289
B MacMahon United States	5	3 0.0×	24 0.4×	51 0.8×	37 0.8×	49 1.1×	7	371
Adolfo Romero Ruiz Spain	12	5 0.1×	37 0.6×	39 0.6×	5 0.1×	17 0.4×	39	468
Mengdong He United States	12	3 0.0×	53 0.8×	12 0.2×	36 0.8×	61 1.4×	19	351
Shahin Roshani Iran	10	19 0.2×	51 0.8×	65 1.0×		31 0.7×	19	256
Edmund Njeru Njagi United Kingdom	10	4 0.0×	18 0.3×	158 2.4×	60 1.3×	56 1.2×	24	370

Countries citing papers authored by Charles Anello

Since Specialization

Citations

This map shows the geographic impact of Charles Anello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Anello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Anello more than expected).

Fields of papers citing papers by Charles Anello

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Anello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Anello. The network helps show where Charles Anello may publish in the future.

Co-authorship network of co-authors of Charles Anello

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Anello. A scholar is included among the top collaborators of Charles Anello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Anello. Charles Anello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Anello, Charles & Suzanne White Junod. (2013). Contributions of Robert T. O’Neill to the Evolution of Regulatory Statistical Science. Statistics in Biopharmaceutical Research. 5(3). 262–279.

Solórzano, Carmen C., et al.. (2008). Sporadic Primary Hyperparathyroidism in Young Individuals: Different Disease and Treatment?. Journal of Surgical Research. 155(1). 100–103. 26 indexed citations

Solórzano, Carmen C., et al.. (2008). QS22. Sporadic Primary Hyperparathyroidism in Young Adults: Different Disease and Treatment?. Journal of Surgical Research. 144(2). 279–279. 1 indexed citations

Goodwin, W. Jarrard, Giovana R. Thomas, Dorothy F. Parker, et al.. (2007). Unequal burden of head and neck cancer in the United States. Head & Neck. 30(3). 358–371. 114 indexed citations

Anello, Charles, Robert T. O’Neill, & Satya D. Dubey. (2005). Multicentre trials: a US regulatory perspective. Statistical Methods in Medical Research. 14(3). 303–318. 31 indexed citations

Anello, Charles. (1999). Emerging and recurrent issues in drug development. Statistics in Medicine. 18(17-18). 2301–2309. 2 indexed citations

D’Agostino, Ralph B., et al.. (1998). The effectiveness of antihistamines in reducing the severity of runny nose and sneezing: A meta-analysis*. Clinical Pharmacology & Therapeutics. 64(6). 579–596. 20 indexed citations

Anello, Charles & Robert T. O’Neill. (1996). Does Research Synthesis Have a Place in Drug Regulatory Policy? Synopsis of Issues: Assessment of Safety and Postmarketing Surveillance. Clinical Research and Regulatory Affairs. 13(1). 13–21. 11 indexed citations

O’Neill, Robert T. & Charles Anello. (1996). Does Research Synthesis Have a Place in Drug Regulatory Policy? Synopsis of Issues: Assessment of Efficacy and Drug Approval. Clinical Research and Regulatory Affairs. 13(1). 23–29. 3 indexed citations

10.

Anello, Charles & Joseph L. Fleiss. (1995). Exploratory or analytic meta-analysis: Should we distinguish between them?. Journal of Clinical Epidemiology. 48(1). 109–116. 71 indexed citations

11.

Knapp, Deanne E., et al.. (1991). Completeness of Adverse Drug Experience Reporting by Manufacturers to the FDA. Drug Information Journal. 25(4). 599–606. 1 indexed citations

12.

Anello, Charles, et al.. (1991). Technological Developments with the FDA Adverse Drug Reaction File System. Drug Information Journal. 25(1). 19–28. 1 indexed citations

13.

Anello, Charles. (1989). Electronic Submission of Periodic Reports. Drug Information Journal. 23(2). 221–224. 1 indexed citations

14.

Anello, Charles, et al.. (1988). A Microcomputer-Based Data Entry System for Reporting Adverse Drug Reactions in the United States. Drug Information Journal. 22(1). 61–70. 1 indexed citations

15.

Faich, Gerald A., Julie B. Milstien, Charles Anello, & Carlene Baum. (1987). Sources of Spontaneous Adverse Drug Reaction Reports Received by Pharmaceutical Manufacturers. Drug Information Journal. 21(3). 251–255. 5 indexed citations

16.

Baum, Carlene, et al.. (1987). Differences in Manufacturer Reporting of Adverse Drug Reactions to the FDA in 1984. Drug Information Journal. 21(3). 257–266. 7 indexed citations

17.

Faich, Gerald A., et al.. (1986). Toxic shock syndrome and the vaginal contraceptive sponge.. PubMed. 255(2). 216–8. 25 indexed citations

18.

Kennedy, Dianne L., et al.. (1983). RELATIONSHIP OF ORAL CONTRACEPTIVE ESTROGEN DOSE TO AGE1. American Journal of Epidemiology. 117(2). 153–159. 8 indexed citations

19.

Anello, Charles. (1983). Statistical Issues of Comparative Clinical Trials. Drug Information Journal. 17(2). 55–62. 3 indexed citations

20.

Anello, Charles. (1972). FDA principles on clinical investigations.. PubMed. 8(2). 31–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact